Stockscreener 앱 받기
13.78
0.97%
-0.135
전일 마감가:
$13.91
열려 있는:
$13.596
하루 거래량:
23,489
Relative Volume:
2.25
시가총액:
$3.88B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$13.09
$14.01
1주일 범위
$13.09
$17.80
52주 변동 폭
$13.09
$17.80
Vicore Pharma Holding Ab Adr Stock (VCRE) Company Profile
Compare VCRE vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCRE
Vicore Pharma Holding Ab Adr
|
13.78 | 3.88B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vicore Pharma Holding Ab Adr 주식(VCRE)의 최신 뉴스
Free cash flow per share of Vicore Pharma Holding AB Sponsored ADR – FWB:6Y40 - TradingView
Total revenue of Vicore Pharma Holding AB Sponsored ADR – FWB:6Y40 - TradingView
Total operating expenses of Vicore Pharma Holding AB Sponsored ADR – FWB:6Y40 - TradingView
Vicore Pharma Holding AB Sponsored ADR Earnings and Revenue – FWB:6Y40 - TradingView
VCRE|Vicore Pharma Holding AB ADR|Price:14.124|Chg%:-0.901 - TradingKey
Citi named depositary bank for Vicore Pharma’s US shares - scanx.trade
TradingKey - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
Vicore Pharma Holding AB ADR (VCRE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vicore Pharma Holding AB ADR (VCRE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vicore Pharma Holding AB ADR (VCRE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Vicore Pharma Holding AB ADR - TradingKey
Vicore Pharma Holding AB ADR (VCRE) Institutional Confidence - TradingKey
Citibank Announces $1.5 Billion Redemption of 4.929% Notes Due 2026 and $1 Billion Redemption of Floating Rate Notes Due 2026 - Business Wire
Vicore Pharma Pursues US Dual Listing, Files Registration Statement with the SEC - ACCESS Newswire
Citi Announces 2026 Investor Day - Business Wire
Citi Appointed as Depositary Bank for Rightmove Plc’s ADR Program - Business Wire
Citigroup Reports First Quarter 2026 Results - Business Wire
C Stock Price | Analyst Target 152.00 & Strong Buy Consensus - eToro
Vicore Pharma Holding Ab Adr (VCRE) 재무 분석
Vicore Pharma Holding Ab Adr (VCRE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
2.64%
자본화:
|
볼륨(24시간):